Synthesis of 4-formyl estrone using a positional protecting group and its conversion to other C-4-substituted estrogens

Journal of Organic Chemistry

Volumn 72, Issue 23, 2007, Pages 8824-8830

  Liu, Yong ^a   Kim, Byoungmoo ^a   Taylor, Scott D ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN 4-CARBOXYESTRONE; ESTRONE;

ALCOHOLS; FORMALDEHYDE; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

KETONES;

2 TERT BUTYL ESTRONE; 4 HYDROXYMETHYLESTRONE; 4 METHYLESTRONE; DICHLOROMETHANE; ESTROGEN 4 CARBOXYESTRONE; ESTROGEN DERIVATIVE; ESTRONE DERIVATIVE; FORMALDEHYDE; FORMIC ACID DERIVATIVE; MAGNESIUM CHLORIDE; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; DRUG SYNTHESIS; QUANTUM YIELD; REACTION ANALYSIS;

ESTROGENS; ESTRONE; MOLECULAR CONFORMATION; STEREOISOMERISM;

EID: 35948995254     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo7017075     Document Type: Article

References (38)

1. Fullerton, D. S. Textbook of Organic, Medicinal and Pharmaceutical Chemistry; Delgado, J. N., Remers, W. A., Eds.; Lippincott Williams & Wilkins: New York, 1998; Chapter 23.
2. For a review of the biology and regulation of STS, see: Reed, M. J.; Purohit, A.; Woo, L. W.; Newman, S. P.; Potter, B. V. Endocr. Rev. 2005, 26, 171.
3. For a review on STS inhibitors see: Nussbaumer, P.; Billich, A. Med. Res. Rev. 2004, 24, 529.
4. For a review on aryl sulfatases, see: Hanson, S. R.; Best, M. D.; Wong, C. H. Angew. Chem., Int. Ed. 2004, 43, 5736.
5. (a) Organon, N. V. Neth. Patent 6506542, 1967.
6. (b) De Winter, M. S.; Ribbers, J. E.; U.S. Patent 3579543, 1971.
7. Pert, D. J.; Ridley, D. D. Aust. J. Chem. 1989, 42, 405.
8. Peters, R. H.; Chao, W.-R.; Sato, B.; Shigeno, K.; Zaveri, N. T.; Tanabe, M. Steroids 2003, 68, 97.
9. Singh, V.; Lahiri, S.; Kane, V. V.; Stey, T.; Stalke, D. Org. Lett. 2003, 5, 2199.
10. Holt, D. A.; Levy, M. A.; Ladd, D. L.; Oh, H-J.; Erb, J. M.; Heaslip, J. I.; Brandt, M.; Metcalf, B. W. J. Med. Chem. 1990, 33, 937.
11. Utne, T.; Jobson, R. B.; Landgraf, F. W. J. Org. Chem. 1968, 33, 1654.
12. This assumes a yield of 93% for the oxidation step (see ref 7) and 80% for the bromination (see ref 10).
13. Labrie, F.; Provencher, L.; Gauthier, S. Int. Appl. WO2004089971, 2004; Chem. Abstr. 2004, 141, 366369.
14. This high level of selectivity for the 4-position is unusual for an electrophilic aromatic substitution (EAS) on E1. All other reported EAS reactions on E1 (not just bromination) always give mixtures of the 2- and 4-isomeric products (plus disubstituted product) and the 2-isomer usually dominates. Other brominating agents do not give the same degree of selectivity as NBA. See: Numazawa, M.; Ogura, Y.; Kimura, K.; Nagaoka, M. J. Chem. Res., Syn. 1985, 11, 348. No explanation has been put forth to explain the high level of selectivity obtained with NBA.
15. Xi, F.; Kamal, F.; Schenerman, M. A. Tetrahedron Lett. 2002, 43, 1395.
16. Cha, J. S.; Jang, S. H.; Kwon, S. Y. Bull. Korean Chem. Soc. 2002, 23, 1697.
17. This synthesis of 9 (33% in three steps from E1) is a considerable improvement over the literature synthesis of 9 which was accomplished in a 21% yield over 6 steps starting from estradiol. See ref 17.
18. Lovely, C. J.; Bhat, A. S.; Coughenour, H. D.; Gilbert, N. E.; Brueggemeier, R. W. J. Med. Chem. 1997, 40, 3756.
19. Tamura, K.; Kato, Y.; Ishikawa, A.; Kato, Y.; Himori, M.; Yoshida, M.; Takashima, Y.; Suzuki, T.; Kawabe, Y.; Cynshi, O.; Kodama, T.; Niki, E.; Shimizu, M. J. Med. Chem. 2003, 46, 3083.
20. Suzuki, Y.; Takahashi, H. Chem. Pharm. Bull. 1983, 31, 1751.
21. (a) Casiraghi, G.; Casnati, G.; Puglia, G.; Sartori, G.; Terenghi, G. J. Chem. Soc., Perkin Trans. 1 1980, 1862.
22. (b) Casiraghi, G.; Casnati, G.; Cornia, M.; Pochini, A.; Puglia, G.; Sartori, G.; Ungaro, R. J. Chem. Soc., Perkin Trans. 1, 1978, 318.
23. (c) Aldred, R.; Johnston, R.; Levin, D.; Neilan, J. J. Chem. Soc., Perkin Trans. 1, 1994, 1823.
24. (d) Hofslokken, N., I.; Skattebol, L. Acta Chim. Scand. 1999, 54, 258.
25. Cushman, M.; He, H.-M.; Katzenellenbogen, J. A.; Lin, C. M.; Hamel, E. J. Med. Chem. 1995, 38, 2041.
26. Kulka, M. J. Am. Chem. Soc., 1954, 76, 5469.
27. For a review on the de-tert-butylation of substituted arenes, see: Saleh, S. A.; Tashtoush, H., I. Tetrahedron, 1998, 53, 14157.
28. Lunn, W. H. W.; Farkas, E. Tetrahedron 1968, 24, 6773.
29. Goendoes, G.; Dombi, G. Monatsh. Chem. 2002, 133, 1279.
30. 3, 2.5 mL of 1.5 M NaOH, 20 mg benzyltriethylammonium chloride in 2.5 mL 95% ethanol then reflux for 20 h. See ref 6). However, even after 24 h reflux, most of the starting material remained unreacted and only a 9% yield of 4-formylated product was obtained. Adding additional base or chloroform at various time intervals and increasing the reaction times did not result in improved yields.
31. We found that subjecting E1 to these conditions yields a mixture of 2-FE1 (major) and 4-FE1 (minor) as well as unidentified byproducts.
32. Triol 15 has been prepared previously by Lovely et al. in five steps starting from E2 in an overall yield of 13% (see ref 17). We have achieved its synthesis in 4 steps starting from E1 in 33% yield and we have not attempted to optimize the reduction reaction.
33. Compound 4 was obtained by Singh et al. as a byproduct in the synthesis of 2-hydroxymethyl estrone. This was achieved by hydroxymethylation of estrone protected at the 17-position with a 1,3-dioxolane ketal followed by removal of the ketal protecting group. The hydroxymethylation gave a 35% yield of the 2- and 4-isomers in a 5:1 ratio which could not be separated until the ketal protecting group was removed. The overall yield of 4 was 6%. See ref 8. We have prepared compound 4 in a 55% yield starting from E1.
34. This synthesis of 6 (50% from E1) represents a dramatic improvement over the literature procedure which has been prepared by a multistep procedure in less than 3% yield starting from expensive 19-nortestosterone. See ref 9 and references therein.
35. Bayle, J. P.; Perez, F.; Courtieu, J. Bull. Chem. Soc. Fr. 1990, 127, 565.
36. Garbaccio, R. M.; Stachel, S. J.; Baeschlin, D. K.; Danishefsky, S. J. J. Am. Chem. Soc. 2001, 123, 10903.
37. Lewis, A.; Stefanuti, I.; Swain, S. A.; Smith, S. A.; Taylor, R. J. K. Org. Biomol. Chem. 2003, 1, 104.
38. Inhibition studies with compounds 3-6 and steroid sulfatase are in progress. The results of these studies will be reported elsewhere.